Courtney R. Moore
Adelaide, SA 5000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Targeting Prostate Cancer Cells Using Anti-Sortilin and Anti-Syndecan-1 Antibody Drug Conjugates.
Journal: International journal of molecular sciences
Published: October 16, 2025
Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers.
Journal: Scientific data
Published: January 31, 2024
Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression.
Journal: British journal of cancer
Published: October 22, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
Journal: Cancers
Published: May 19, 2023
Altered endosomal-lysosomal biogenesis in melanoma.
Journal: Neoplasia (New York, N.Y.)
Published: May 04, 2023
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression.
Journal: Scientific reports
Published: March 15, 2023
Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread.
Journal: Pathology
Published: February 02, 2023
A Paradigm in Immunochemistry, Revealed by Monoclonal Antibodies to Spatially Distinct Epitopes on Syntenin-1.
Journal: International journal of molecular sciences
Published: November 13, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026